Frontiers in the treatment of glioblastoma: Past, present and emerging
Glioblastoma (GBM) is one of the most aggressive cancers of the brain. Despite extensive
research over the last several decades, the survival rates for GBM have not improved and …
research over the last several decades, the survival rates for GBM have not improved and …
A review on anti-tumor mechanisms of coumarins
Y Wu, J Xu, Y Liu, Y Zeng, G Wu - Frontiers in oncology, 2020 - frontiersin.org
Coumarins are a class of compound with benzopyrone as their basic structure. Due to
abundant sources, easy synthesis, and various pharmacological activities, coumarins have …
abundant sources, easy synthesis, and various pharmacological activities, coumarins have …
Synthesis and biological evaluation of benzofuran piperazine derivatives as potential anticancer agents
TJ Schumacher, N Sah, K Palle, J Rumbley… - Bioorganic & Medicinal …, 2023 - Elsevier
This work describes about the synthesis and evaluation of substituted benzofuran
piperazines as potential anticancer agents. The synthesized candidates have been …
piperazines as potential anticancer agents. The synthesized candidates have been …
Role of human monocarboxylate transporter 1 (hMCT1) and 4 (hMCT4) in tumor cells and the tumor microenvironment
T Liu, S Han, Y Yao, G Zhang - Cancer Management and Research, 2023 - Taylor & Francis
In recent years, the abnormal glucose metabolism of tumor cells has attracted increasing
attention. Abnormal glucose metabolism is closely related to the occurrence and …
attention. Abnormal glucose metabolism is closely related to the occurrence and …
Novel strategies to improve tumour therapy by targeting the proteins MCT1, MCT4 and LAT1
Y Wang, L Qin, W Chen, Q Chen, J Sun… - European Journal of …, 2021 - Elsevier
Poor selectivity, potential systemic toxicity and drug resistance are the main challenges
associated with chemotherapeutic drugs. MCT1 and MCT4 and LAT1 play vital roles in …
associated with chemotherapeutic drugs. MCT1 and MCT4 and LAT1 play vital roles in …
Anticancer mechanism of coumarin-based derivatives
AK Yadav, RM Shrestha, PN Yadav - European Journal of Medicinal …, 2024 - Elsevier
The structural motif of coumarins is related with various biological activities and
pharmacological properties. Both natural coumarin extracted from various plants or a new …
pharmacological properties. Both natural coumarin extracted from various plants or a new …
Lactate and lactate transporters as key players in the maintenance of the Warburg effect
Reprogramming of energy metabolism is a key hallmark of cancer. Most cancer cells display
a glycolytic phenotype, with increased glucose consumption and glycolysis rates, and …
a glycolytic phenotype, with increased glucose consumption and glycolysis rates, and …
Synthesis and anticancer activity of new coumarin-3-carboxylic acid derivatives as potential lactate transport inhibitors
H Ji, Y Tan, N Gan, J Zhang, S Li, X Zheng… - Bioorganic & Medicinal …, 2021 - Elsevier
As an oncometabolite, lactate plays a very important role in tumor proliferation, metastasis,
angiogenesis, immune escape and other tumor biological functions. Pharmacological …
angiogenesis, immune escape and other tumor biological functions. Pharmacological …
Identification of a selective inhibitor of human monocarboxylate transporter 4
Y Futagi, M Kobayashi, K Narumi, A Furugen… - … and biophysical research …, 2018 - Elsevier
The human monocarboxylate transporters (hMCTs/SLC16As) mediate the uptake of various
monocarboxylates. Several isoforms of hMCTs are expressed in cancerous tissue as well as …
monocarboxylates. Several isoforms of hMCTs are expressed in cancerous tissue as well as …
[HTML][HTML] Novel N, N-dialkyl cyanocinnamic acids as monocarboxylate transporter 1 and 4 inhibitors
S Jonnalagadda, SK Jonnalagadda, CT Ronayne… - Oncotarget, 2019 - ncbi.nlm.nih.gov
Potent and dual monocarboxylate transporter (MCT) 1 and 4 inhibitors have been
developed for the first time as potential anticancer agents based on α-cyanocinnamic acid …
developed for the first time as potential anticancer agents based on α-cyanocinnamic acid …